Tg Therapeutics (TGTX) Interest Coverage Ratio (2011 - 2026)

Tg Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 4.54 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 255.71% year-over-year to 4.54 in Q1 2026; TTM through Mar 2026 was 5.4, a 82.14% increase from a year earlier, with the FY2025 full-year figure at 1.28, up 215.48% from the prior year.
• Interest Coverage Ratio retreated to 4.54 in Q1 2026 per TGTX's latest filing, from 7.73 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 19.79 in Q3 2023 and bottomed at 13.01 in Q1 2023.
• The 5-year median for Interest Coverage Ratio is 0.94 (2024), against an average of 0.01.
• Across the five-year window, Interest Coverage Ratio plunged 421.96% in 2023 and jumped 713.87% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 12.34 in 2022, then soared by 171.6% to 8.84 in 2023, then slumped by 71.71% to 2.5 in 2024, then surged by 209.17% to 7.73 in 2025, then tumbled by 41.28% to 4.54 in 2026.
• Per Business Quant, the three latest TGTX Interest Coverage Ratio figures stand at 4.54 (Q1 2026), 7.73 (Q4 2025), and 2.66 (Q3 2025).